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  Abstract 
Advances in ultrasound technology over recent times, 
mean that the once controversial area of aneuploidy 
detection is becoming a popular topic for sonographers 
worldwide.  Improved resolutions from high end machines 
mean that very subtle anatomic variants may have a part to 
play in the detection of chromosomal abnormalities. When 
combined with laboratory testing and risk assessment tools, 
early detection of these soft markers can provide a 
rationale for the diagnosis and management of fetal 
chromosomal defects.           
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Referral for further management will depend on institutional 
guidelines and client preference, however the majority of 
settings advocate further investigations if two or more 
anatomic variations are noted on ultrasound.  The number 
of soft markers detected can have a significant bearing on 
the risk for aneuploidy.  Finding one soft marker determines 
a risk of 2%, it rises to 11% in the presence of two  
softmarkers and up to 66% with five and in turn 92% with 
eight (Zalel, 2013).  
 
Currently in Ireland there is no standardized policy for 
second trimester aneuploidy screening. The detailed 
anomaly scan is usually the first screening tool applied to 
determine structural normality, exposing abnormal 
anatomic variants as possible warning signs. Referral for 
follow up and further investigation often poses dilemmas 
due to the lack of a set classification critique and a 
universal policy for management. Overall with proper 
awareness of the specific soft markers and follow up care 
advancements, sonographers can strive to improve client 
care in this much debated field of sonography. 
 
The second trimester detailed anomaly scan remains a 
highly effective screening tool for the assessment of 
structural normality and recognition of fetal abnormalities 
(Liau et al, 2014). Improvements in ultrasound resolution 
now mean that subtle anatomic variations referred to as 
“soft markers” are more detectable, often leaving 
practitioners in a dilemma regarding referral for further 
testing and follow up care pathways. The National Institute 
for Health and Care Excellence recommend early 
screening for aneuploidy and that all women are offered a 
detailed anomaly scan between 18 weeks and 20+6 weeks 
(NICE, 2012).    
The literature is abundant with information defining these 
soft markers and the inclusion criteria varies throughout 
institutions; however the majority of sources have a 
classification list comprising of - choroid plexus cyst, 
intracardiac foci, echogenic bowel, pyelectasis, shortened 
femur, single umbilical artery and mild ventriculomegaly. 
This poster highlights the ultrasound image analysis of the 
most relevant soft markers and discusses the recent 
developments in the field.   
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Figure1: Axial view of the fetal skull demonstrating a 
choroid plexus cyst at level of the posterior ventricle. 
(Green arrow)  
Figure 2: Four chamber view of the fetal heart  
containing an echogenic intracardiac  focus in the left  
ventricular chamber (see arrow).  
Figure 3: Longitudinal view of  the fetal abdomen  
demonstrating an echogenic bowel (left) from Saha et 
al (2012) pg 759, labelled by author and normal 
appearing bowel  (right). 
 The  gain is reduced  to assist  confirmation of 
echogenicity which is similar to bone (Saha et al, 
2012).    
Figure 4: Shows a transverse view of the fetus at the 
level of the kidneys incorporating renal pelvis 
measurements in the anterior-posterior diameter .This 
image portrays a right sided pyelectasis  of  6mm.  
Discussion   
Figure 5: Portrays the umbilical cord insertion at the 
level of the bladder with single artery bifurcation and 
application of colour doppler.  
 On review of the current literature the significance of 
specific soft markers has changed considerably over the 
years. In relation to single umbilical artery as an isolated 
finding, Voskamp et al (2013) undertook a large 
systematic review and meta-analysis and found no 
evidence that fetuses with isolated single umbilical artery 
have an increased risk of aneuploidy compared to a 10% 
risk mentioned in past studies.  
On the other hand the diagnosis of an isolated fetal 
pyelectasis >4mm as a soft marker for Down syndrome 
showed a notable positive and negative likelihood ratio of 
2.78 respectively (Orzechowski and Berghella, 2013).  
In turn a more extended study carried out by 
Agathokleous et al (2013) looked at the various different 
soft markers and their correlation with Down syndrome. 
The positive likelihood ratios are shown in the chart below 
to demonstrate the significance of each individual marker. 
Statistics showed that ventriculomegaly, increased nuchal 
fold,  aberrant right subclavian artery and hypoplastic 
nasal bone yielded the highest positive likelihood results.        
  
Figure 6: Demonstrates the posterior ventricles  with 
mild ventriculomegaly of 13mms noted. 
Ventriculomegaly is described as cerebral ventricular 
measurement above 10mms (Agathokleous et al, 
2013).  
Figure 1: Choroid plexus cyst 
Figure 2: Echogenic intracardiac focus   
Figure 3: Echogenic bowel/ normal bowel 
Figure 6: Mild ventriculomegaly 
Figure 5: Single umbilical artery 
Figure 4: Pyelectasis 
Although CVS and amniocentesis remain the definitive 
diagnostic tests in the detection of aneuploidy, recent 
advances in the field of non-invasive prenatal screening 
of maternal cell free DNA boast significant detection 
results without the added risks to the fetus.  Analysis of 
cell free fetal DNA has detection rates of 99.2% for T21, 
96.3% for T18, 91.0% for T13 and 93.0% for sex 
chromosome aneuploidy (Gil et al, 2015).  
Amniocentesis carries a 1% risk for miscarriage and 
should be carried out after 15 weeks gestation (RCOG, 
2010).   
In relation to ultrasound  the inclusion of the nasal bone 
length as part of the detailed anomaly scan is also 
recommended, particularly in the diagnosis of T21.  
Zalel et al (2013) reviewed studies linking nasal bone 
hypoplasia (NBH) to aneuploidy in the second trimester. 
Findings suggested that NBH was present in  61.8% of 
fetuses with Down syndrome, 1.2% of normal fetuses 
and 3.3% with other chromosomal abnormalities, 
strengthening its  significance as an additional soft 
marker.    
Figure 8 
Figure 8: Image of amniocentesis from  births injury 
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Figure 9: Nasal bone  
Figure 9: Demonstrates a sagittal profile view ideal for  
nasal bone measurement and assessment.    
Figure 7 
Figure 7: Graph summarising  data from Agathokleous et al 
(2013).  
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